ArticleInternal medicine (Tokyo, Japan)2022
Radical Resection for Second EGFR-mutated Primary Lung Cancer Following Immune Checkpoint Inhibitor Monotherapy for Stage IV Lung Adenocarcinoma.
Ryota Horibe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.